TTOO - T2 Biosystems Q3 2021 Earnings Preview
T2 Biosystems (NASDAQ:TTOO) is scheduled to announce Q3 earnings results on Thursday, November 4th, after market close. The consensus EPS Estimate is -$0.09 and the consensus Revenue Estimate is $5.8M (+10.5% Y/Y). The company's shares fell more than 6% in reaction to posting second-quarter results and providing a cash position update, in August. Recently, T2 Biosystems announced that the Biomedical Advanced Research and Development Authority (BARDA) exercised a contract option providing an additional $6.4M of funding for the company. Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 2 downward. The company's shares have fallen more than 35% year to date.
For further details see:
T2 Biosystems Q3 2021 Earnings Preview